Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Med. oral patol. oral cir. bucal (Internet) ; 19(6): e612-e615, nov. 2014. tab
Artigo em Inglês | IBECS | ID: ibc-130357

RESUMO

OBJECTIVES: The purpose of this study was to compare the use of amoxicillin (1g) vs amoxicillin and clavulanate (875/125mg) after extraction of retained third molars for prevention of infectious complications. Study DESIGN: The study involved 546 patients attending for removal a retained third molar and divided in to two groups: Group 1 - amoxicillin and clavunate (875/125mg) group (n=257) and Group 2 - amoxicillin (1g) group (n=289). All patients were recalled for investigating the possibility of infection, presence of diarrhea and further analgesic intake. RESULTS: From a total of 546 patients, the frequency of infection was 1.4%, without no statistically differences between the two groups. Group 1 showed statistically higher presence of patients with gastrointestinal complications (p > 0.05). In 546 patients, 2.7% of patients reported severe pain that would not relieve with medication. CONCLUSIONS: The results of our study show that the use of amoxicillin (1g) and amoxicillin and clavunate (875/125mg) is similar efficacious in preventing infection after retained third molar extraction but amoxicillin and clavunate (875/125mg) produces more gastrointestinal discomfor


Assuntos
Humanos , Combinação Amoxicilina e Clavulanato de Potássio/uso terapêutico , Amoxicilina/uso terapêutico , Dente Serotino/cirurgia , Extração Dentária/métodos , Antibioticoprofilaxia/métodos , Complicações Pós-Operatórias/prevenção & controle , Infecção da Ferida Cirúrgica/prevenção & controle
2.
Med Oral Patol Oral Cir Bucal ; 19(6): e612-5, 2014 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-24880449

RESUMO

OBJECTIVE: The purpose of this study was to compare the use of amoxicillin (1g) vs amoxicillin and clavulanate (875/125mg) after extraction of retained third molars for prevention of infectious complications. STUDY DESIGN: The study involved 546 patients attending for removal a retained third molar and divided in to two groups: Group 1 - amoxicillin and clavunate (875/125mg) group (n=257) and Group 2 - amoxicillin (1g) group (n=289). All patients were recalled for investigating the possibility of infection, presence of diarrhea and further analgesic intake. RESULTS: From a total of 546 patients, the frequency of infection was 1.4%, without no statistically differences between the two groups. Group 1 showed statistically higher presence of patients with gastrointestinal complications (p>0.05). In 546 patients, 2.7% of patients reported severe pain that would not relieve with medication. CONCLUSION: The results of our study show that the use of amoxicillin (1g) and amoxicillin and clavunate (875/125mg) is similar efficacious in preventing infection after retained third molar extraction but amoxicillin and clavunate (875/125mg) produces more gastrointestinal discomfort.


Assuntos
Combinação Amoxicilina e Clavulanato de Potássio/uso terapêutico , Amoxicilina/uso terapêutico , Antibacterianos/uso terapêutico , Infecções Bacterianas/prevenção & controle , Dente Serotino/cirurgia , Complicações Pós-Operatórias/prevenção & controle , Extração Dentária , Inibidores de beta-Lactamases/uso terapêutico , Adulto , Feminino , Humanos , Masculino
3.
Rev. esp. cir. oral maxilofac ; 35(2): 59-68, abr.-jun. 2013.
Artigo em Espanhol | IBECS | ID: ibc-112135

RESUMO

Introducción y objetivo. El uso de materiales de relleno facial para la corrección de arrugas, pliegues y otros defectos es cada vez más demandado por nuestros pacientes. Se trata de materiales que al ser infiltrados provocan un aumento de volumen. Pueden clasificarse en función del tiempo de permanencia en el cuerpo en temporales o biodegradables (entre 4 y 8 meses), semipermanentes (entre 12 y 18 meses) y permanentes (no biodegradables). Nuestro trabajo tiene por objeto repasar los materiales de relleno que actualmente están aprobados por la Agencia del Medicamento en septiembre de 2010. Material y métodos. Hemos revisado a través de la página web oficial de la Agencia Española del Medicamento los materiales de rellenos aprobados por la misma en septiembre de 2010, para posteriormente hacer una revisión de la literatura científica más reciente sobre ellos. Resultados. Estos son: el ácido hialurónico, colágeno y agarosa para los materiales temporales; el ácido poliláctico, la hidroxiapatita de calcio y la policaprolactona como materiales semipermanentes; y el polimetilmetracrilato y las acrilamidas en el grupo de los materiales permanentes. Discusión. Las características ideales que debería cumplir un relleno facial son ser biocompatible, no cancerígeno, no teratógeno, no migratorio y tener resultados satisfactorios con durabilidad. Estos tipos de materiales son productos sanitarios y deben cumplir la normativa de la Agencia Española del Medicamento. Por tanto, solo deben ser utilizados por profesionales cualificados y preparados específicamente en este terreno. Conclusiones. Los rellenos temporales son los que más se emplean con fines estéticos. Sin embargo, es necesario el conocimiento de la naturaleza de cada material, sus indicaciones y las posibles complicaciones que pueden aparecer tras su uso para poder así sacar el máximo beneficio y obtener los mejores resultados posibles(AU)


Introduction and aim. The use of facial filling materials for the correction of wrinkles, folds and other faults is increasingly demanded by our patients. They are materials that on having been infiltrated lead to an increase in volume. These products can be classified depending on the time of they remain in the body and as temporary or biodegradable (between 4 and 8 months), semi-permanent (between 12 and 18 months) and permanent (not biodegradable). The aim of this work is to review the facial filling materials that are currently approved by the Spanish Medicines and Health Devices Agency (AEMPS) in September, 2010. Material and methods. The official web page of the AEMPS was searched for facial filling materials approved in September, 2010. A review was then made of the most recent scientific literature on these materials. Results. The temporary materials used are hyaluronic acid, collagen and agarose gel, with polylactic acid, calcium hydroxyapatite, and polycaprolactone as semi-permanent materials, and polymethyl methacrylate and the acrylamides in the group of the permanent materials. Discussion. The ideal characteristics for a facial filler are that it should be biocompatible, non-carcinogenic, non-teratogenic, non-migratory, and have satisfactory results with permanence. These types of materials are health products and must comply with the regulations of the AEMPS. Therefore, they must only be used by qualified professionals specifically trained in this area. Conclusions. The temporary face fillers are those that are most used for aesthetic purposes. Nevertheless, knowledge is required on the nature of every material, its indications, and the possible complications that can appear after his use, to be able to achieve the maximum benefits and obtain the best possible results(AU)


Assuntos
Humanos , Masculino , Feminino , Adulto , Implantes Dentários/normas , Implantes Dentários , Materiais Dentários/uso terapêutico , Ácido Hialurônico/uso terapêutico , Colágeno/uso terapêutico , Sefarose/uso terapêutico , Implantes Absorvíveis , Durapatita/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...